Calls for aggressive control of semaglutide supply amid ongoing global shortage

The TGA needs to do more to address the 'unique and worrying' situation, experts say
Sarah Simpkins
A/Prof Sof Andrikopoulos
Associate Professor Sof Andrikopoulos

Leading doctors have urged health authorities to aggressively control supply of semaglutide, including a potential emergency stockpile, as the global shortage of the drug drags on.

This week, AMA president Professor Steve Robson said reserves of the GLP-1 receptor agonist should be set aside for patients with type 2 diabetes in a bid to thwart off-label prescribing for weight loss.